Wird geladen...

Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection

Immune-checkpoint inhibitors (ICPIs), including antibodies against cytotoxic T-lymphocyte associated antigen 4 and programmed cell death protein 1, have been shown to induce durable complete responses in a proportion of patients in the first-line and refractory setting in advanced melanoma and renal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Michael Flynn, Lisa Pickering, James Larkin, Samra Turajlic
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publishing 2018-06-01
Schriftenreihe:Therapeutic Advances in Medical Oncology
Online Zugang:https://doi.org/10.1177/1758835918777427
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!